Are drugs for rare diseases "essential"?
Reidenberg
Marcus M
MM
D003362:Cost-Benefit Analysis; D018954:Drugs, Essential; D006801:Humans; D009965:Orphan Drug Production; D035583:Rare Diseases / Q000188:drug therapy*; D040841:Resource Allocation; D012935:Social Justice; D014944:World Health Organization
D018954:Drugs, Essential